Bowel cancer
Intestinal cancer (carcinoma of rectum) is a common malignant tumor in the gastrointestinal tract. Its incidence rate is second only to stomach and esophageal cancer. It is the most common part of colorectal cancer (accounting for about 60%). The vast majority of patients are over 40 years old, and about 15% are under 30 years old. It is more common in men, with a male-to-female ratio of 2-3:1. Intestinal cancer should be actively prevented.
-
Site of disease:
intestinal -
Infectious :
Not contagious -
Frequent population:
Middle-aged and elderly people -
Related symptoms:
Blood in stool Loss of appetite Weight loss Feeling of incomplete defecation Abnormal bowel movement frequency -
Concurrent disease:
Related Drugs
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Nimustine hydrochloride
Indication: Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer:
Bei Jing Scrianen Pharmaceutical Co., Ltd.
Sodium folinate for injection
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.). 2. Used to prevent and treat severe toxic effects caused by overdose or high-dose treatment of methotrexate. 3. Can also be used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil to treat advanced colon and rectal cancer.
Manufacturer:
Wuhan Humanwell Pharmaceutical Co., Ltd.
Sodium folinate for injection
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.). 2. Used to prevent and treat severe toxic effects caused by overdose or high-dose treatment of methotrexate. 3. Can also be used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil to treat advanced colon and rectal cancer.
Manufacturer:
Wuhan Humanwell Pharmaceutical Co., Ltd.
Sodium folinate for injection
Indication: 1. Used as an antidote for folic acid antagonists (such as methotrexate, pyrimethamine or trimethoprim, etc.). 2. Used to prevent and treat severe toxic effects caused by overdose or high-dose treatment of methotrexate. 3. Can also be used to treat megaloblastic anemia caused by folic acid deficiency. 4. Used in combination with 5-fluorouracil to treat advanced colon and rectal cancer.
Manufacturer:
Wuhan Humanwell Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Yuanda Pharmaceutical Huangshi Feiyun Pharmaceutical Co., Ltd.
Hydroxycamptothecin injection
Indication: Anti-tumor drugs. Suitable for primary liver cancer, gastric cancer, bladder cancer, colorectal cancer, head and neck epithelial cancer, leukemia and other malignant tumors.
Manufacturer:
Harbin Medisan Pharmaceutical Co., Ltd.
Related Ingredients